Award-winning British Recycling Project, NEXTLOOPP, Hits Bullseye in Plastics Recycling Ahead of COP26
20.10.2021 12:30:00 EEST | Business Wire | Press release
NEXTLOOPP, the groundbreaking project by Nextek Limited, that recently won the overall award for ‘Best Sustainable Packaging Innovation’ at Packaging Europe’s Sustainability Awards - https://packagingeurope.com/sustainability-awards-2021-winners-revealed/ has revealed the results of its highly successful tracer-based sorting trials held at TOMRA (Germany) in September 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211020005464/en/
NEXTLOOPP participants in the global project to close the loop on food-grade Polypropylene (Graphic: Business Wire)
The trials, to specifically sort food-grade plastic packaging waste, achieved a resounding 99.9% sorting purity at maximum production speed.
This demonstrates that Nextek’s unique technology efficiently differentiates food packaging from non-food packaging to meet the standards required by the Food Standards Authorities in the UK and EU. Being able to identify and sort any number of pack variants from bleach bottles to milk bottles in any plastic type is a world-first that will transform the way we recycle the prolific volume of single-use post-consumer food packaging waste back into circular applications.
This announcement marks 12 months of NEXTLOOPP’s programme to close the loop on food-grade Polypropylene (FGPP), which is the biggest plastic fraction in the FMCG sector. In the UK alone, 210,000 tonnes of FGPP packaging is used in pots, tubs, trays and films each year, and this cutting-edge innovation creates the opportunity to recycle Polypropylene (PP) back into food packaging.
This also heralds a new era in the plastics packaging recycling industry and the validation of NEXTLOOPP’s PolyPRISMTM ‘plug-and-play’ marker system, as used on TOMRA’s sorting equipment for commercial purposes.
Sorting plastic waste into polymer types is the first of three vital steps needed to close the loop on PP and create a global low carbon economy. The next step requires splitting the plastic packaging into food and non-food fractions. The final step involves NEXTLOOPP’s patented decontamination process, PPristineTM, which unlocks the markets to food packaging. Recycling 63,000 tonnes of PP per annum would save a minimum estimated 105,600 tonnes in CO2 emissions in the UK each year.
“During recent trials held at our TOMRA Test Centre we achieved very promising results on all Polypropylene 3D samples in all test runs with state-of-the-art NIR/VIS technology. We exceeded the required 95% purity for food-grade in each test run. The next important milestones will be a field demonstration as well as demonstrating chemical compliance with food-grade regulation” said Ralph Uepping, Technical Director at TOMRA.
Professor Edward Kosior, founder of Nextek, believes the NEXTLOOPP project is the catalyst to transform current FGrPP recycling and become the next food-grade recycling success story. PET was first and now it’s the turn of PP.
About Nextek Ltd
Nextek is a global sustainability consultancy that provides strategic advice to regional and multi-national organisations and recycling companies. Launched in 2004, Nextek researches and develops innovative strategies and processes within the recycling ecosystem – from designing recycling plants to developing ground-breaking projects for governments and major organisations. Nextek launched NEXTLOOPP, a two-year 37-strong project, to close the loop on food-grade recycled Polypropylene (rPP). This project incorporates unique technological breakthroughs that include innovative sorting and cutting-edge decontamination technologies.
About Tomra
TOMRA is a Norwegian multinational corporation that manufactures collection and sorting products, such as reverse vending machines for the food, recycling and mining industries. TOMRA is the market leader in its industry with over 100,000 installations in 80+ markets worldwide. Its Recycling Division has pioneered the automation of waste sorting.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005464/en/
Contact information
Janine Wood
Email: janinewood@nexteklimited.com
Tel: +44 (0)7831582659
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KILL Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)6.5.2026 05:14:00 EEST | Press release
Samsung Bioepis Co., Ltd. requests that their press release NewsItemId: 20260505353718 “Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)” be killed. The release was issued prematurely by Samsung Bioepis Co., Ltd. The news release will be updated and redistributed in the near future, incorporating further information on SB27.
Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)6.5.2026 02:00:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 study on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), has met its primary pharmacokinetics (PK) endpoints. The randomized, double-blind, three-arm, parallel group, multicenter clinical trial demonstrated pharmacokinetic bioequivalence of SB27 (pembrolizumab) to the reference product Keytruda. Initiated in January 2024, Phase 1 study is being conducted in four countries, and is expected to be completed by November 2026.2 The study assessed pharmacokinetics, efficacy, safety, and immunogenicity of SB27, EU-sourced Keytruda, and US-sourced Keytruda in patients with stage II or IIIA non-small cell lung cancer (NSCLC) following complete resection and adjuvant platinum-based chemotherapy. 163 participants were randomized to receive SB27, EU-sourced Keytruda, or US-sourced Keytruda every 3 weeks, maximum 18 cycles over about 51 weeks, and blood samples were collected. The preliminary pharmacokinetic evaluation indicates t
Megaport Launches Built-In DDoS Protection Enabling On-Demand Network Resilience6.5.2026 01:00:00 EEST | Press release
Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of Megaport DDoS Protection. This new, built-in security capability for Megaport Internet allows customers to filter malicious traffic directly within the Megaport network rather than routing it through a separate or external service, for mission-critical uptime without introducing additional latency or routing complexity. As enterprises increasingly migrate to distributed cloud environments, traditional DDoS mitigation has struggled to keep pace with cloud and distributed infrastructure adoption. Standard ISP solutions often resort to dropping all traffic and taking the service offline to protect the network, while external third-party providers force a "security detour" that reroutes traffic through public infrastructure, introducing significant latency and complexity. Megaport DDoS Protection removes these challenges by integrating fabric-native protection directl
IFF Reports First Quarter 2026 Results5.5.2026 23:23:00 EEST | Press release
IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Consolidated Summary: Management Commentary “IFF is off to a solid start in 2026, with first quarter results that reflect the customer focus and operational execution we’ve been building across the company,” said Erik Fyrwald, CEO of IFF. “We delivered volume growth in all four segments, improved profitability, and generated strong cash flow in the first quarter. As we look ahead, we are maintaining a disciplined approach to how we are planning the balance of the year as the current operating environment remains unsettled. We remained focused on advancing our commercial and innovation pipelines, driving productivity, and working with customers to offset inflation. This – when combined with our solid start to the year – derisks the balance of the year and gives us the confidence to reaffirm our full-year 2026 financial guidance ranges in an uncertain environment. At the same time, w
Logitech Announces Q4 and Full Fiscal Year 2026 Results5.5.2026 23:06:00 EEST | Press release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2026. For Fiscal Year 2026: Sales were $4.84 billion, up 6 percent in US dollars and 4 percent in constant currency compared to the prior year. GAAP operating income was $775 million, up 18 percent compared to the prior year. Non-GAAP operating income was $911 million, up 18 percent compared to the prior year. GAAP earnings per share was $4.80, up 16 percent compared to the prior year. Non-GAAP EPS was $5.78, up 19 percent compared to the prior year. Cash flow from operations was $1.04 billion. The year-ending cash balance was $1.7 billion. The Company returned $768 million of cash to shareholders through its annual dividend payment and share repurchases. For Q4 Fiscal Year 2026: Sales were $1.09 billion, up 7 percent in US dollars and 3 percent in constant currency compared to Q4 of the prior yea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom